U.S. Top Stock Picks from Analysts

PG&E

Market Cap: US$29.6b

Through its subsidiary, Pacific Gas and Electric Company, engages in the sale and delivery of electricity and natural gas to customers in northern and central California, the United States.

JBS

Market Cap: US$14.6b

Operates as a protein and food company worldwide.

QXO

Market Cap: US$14.5b

Distributes roofing, waterproofing, and other building products in the United States.

Centene

Market Cap: US$13.9b

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States.

Moderna

Market Cap: US$12.1b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Aurora Innovation

Market Cap: US$11.1b

Operates as a self-driving technology company in the United States.

BioMarin Pharmaceutical

Market Cap: US$11.0b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Molina Healthcare

Market Cap: US$9.9b

Provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.

VinFast Auto

Market Cap: US$8.4b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

Legend Biotech

Market Cap: US$7.7b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Globus Medical

Market Cap: US$7.6b

A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Corcept Therapeutics

Market Cap: US$7.5b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Revolution Medicines

Market Cap: US$7.1b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Jazz Pharmaceuticals

Market Cap: US$6.8b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Repligen

Market Cap: US$6.5b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Bruker

Market Cap: US$6.1b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Clearwater Analytics Holdings

Market Cap: US$5.7b

Develops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services to insurers, investment managers, corporations, institutional investors, and government entities in the United States and internationally.

Axsome Therapeutics

Market Cap: US$5.5b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Lantheus Holdings

Market Cap: US$4.9b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Alkermes

Market Cap: US$4.8b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Vaxcyte

Market Cap: US$4.7b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Pony AI

Market Cap: US$4.6b

Through its subsidiaries, engages in the autonomous mobility business in the People’s Republic of China, the United States, and internationally.

Chagee Holdings

Market Cap: US$4.6b

Through its subsidiaries, owns, operates, and franchises teahouses under the CHAGEE brand name in the People’s Republic of China and internationally.

Cytokinetics

Market Cap: US$4.4b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Avidity Biosciences

Market Cap: US$4.1b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

ADMA Biologics

Market Cap: US$4.0b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Zai Lab

Market Cap: US$3.8b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Inspire Medical Systems

Market Cap: US$3.7b

A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

Arcellx

Market Cap: US$3.7b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Globant

Market Cap: US$3.7b

Provides technology services worldwide.

Zeta Global Holdings

Market Cap: US$3.7b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

Viking Therapeutics

Market Cap: US$3.6b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Globalstar

Market Cap: US$3.5b

Provides mobile satellite services in the United States, Canada, Europe, Central and South America, and internationally.

CleanSpark

Market Cap: US$3.5b

Operates as a bitcoin mining company in the Americas.

Remitly Global

Market Cap: US$3.5b

Engages in the provision of digital financial services in the United States, Canada, and internationally.

Freshpet

Market Cap: US$3.5b

Manufactures, distributes, and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe.